Deep Brain Stimulation Effects on Gait and Balance in Patients With Parkinson's Disease Trial N/A Terminated May 27, 2021
A Phase 2 Study of CX-8998 in Adults With Tremor Associated With Parkinson's Disease Trial Phase 2 Withdrawn May 27, 2021
AV-101 (L-4-chlorokynurenine) in Parkinson's Disease Subjects With Levodopa-Induced Dyskinesia Trial Phase 2 Unknown May 25, 2021
Usefulness of α-synuclein as a Marker for Early Diagnosis of Parkinson's Disease in Skin Biopsy. Trial N/A Completed May 24, 2021
A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Japanese Participants With Parkinson's Disease Trial Phase 1 Terminated May 24, 2021
Randomised Crossover Trial of DBS of Differential PSA Regions in Parkinson's Disease and Tremor Trial Phase 2 Completed May 17, 2021
More Than a Movement Disorder: Applying Palliative Care to Parkinson's Disease Trial N/A Completed May 13, 2021
Video Dance Class and Unsupervised Physical Activity During Covid-19 Pandemic in People With Parkinson's Disease Trial N/A Unknown May 13, 2021
An Extension Study to Assess the Safety, Tolerability and Efficacy of ABT-SLV187 in Subjects With Advanced Parkinson's Disease and Persistent Motor-Complications Despite Optimized Treatment With Available Anti-Parkinsonian Medications Trial Phase 3 Completed May 11, 2021
Application of Machine Learning Method in Validation of Screening Cognitive Test for Parkinsonisms Trial N/A Completed May 11, 2021
Changes in Metabolic Activity, and Gait Function by Dual-task Cognitive Game-based Treadmill Intervention in Parkinson's Disease. Trial N/A Unknown May 10, 2021
Use and Misuse of Domperidone in Parkinson's Disease in France - Dump Investigation Trial N/A Completed May 10, 2021
Selegiline for the Treatment of Excessive Daytime Sleepiness in Parkinson's Disease Trial Phase 4 Completed May 6, 2021
Efficacy of Levodopa/Benserazide Dispersible Tablet on Response Fluctuations in PD Patients With Delayed ON Trial Phase 4 Completed May 6, 2021
A Study to Test the Safety, Tolerability, and Pharmacokinetics of UCB0599 in Healthy Study Participants and Patients With Parkinson's Disease (PD) Trial Phase 1 Completed May 5, 2021
Potential Use of Autologous and Allogeneic Mesenchymal Stem Cells in Patients With Multiple System Atrophy Trial N/A Unknown May 5, 2021